Literature DB >> 25448316

What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling.

H Ongun Onaran1, Sudarshan Rajagopal2, Tommaso Costa3.   

Abstract

A G protein-coupled receptor (GPCR) is only biologically active when associated with a transduction protein, but it can also switch function by interacting with different types of transduction proteins. Biased agonism arises when the ligand induces the receptor to engage distinct transduction proteins with different efficacies. We briefly review the concept of ligand efficacy, from the classical empirical idea to the current mechanistic views of allosteric regulation in proteins. A combination of these theoretically distinct ideas and methodologies allows us to distinguish true ligand bias from divergences of signalling caused by the system. We also demonstrate a rigorous mathematical connection between the intrinsic efficacy of classical receptor theory and the energetic effect that makes a ligand capable of stabilizing receptor-transducer association in the ternary complex model. This relationship unifies different definitions of efficacy and provides a rational basis for quantifying biased agonism.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Keywords:  GPCR

Mesh:

Substances:

Year:  2014        PMID: 25448316     DOI: 10.1016/j.tips.2014.09.010

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  17 in total

Review 1.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

Review 2.  The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors.

Authors:  Jeffrey S Smith; Sudarshan Rajagopal
Journal:  J Biol Chem       Date:  2016-03-16       Impact factor: 5.157

Review 3.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  An evaluation of the operational model when applied to quantify functional selectivity.

Authors:  Xiao Zhu; David B Finlay; Michelle Glass; Stephen B Duffull
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

Review 5.  Biased signalling: from simple switches to allosteric microprocessors.

Authors:  Jeffrey S Smith; Robert J Lefkowitz; Sudarshan Rajagopal
Journal:  Nat Rev Drug Discov       Date:  2018-01-05       Impact factor: 84.694

6.  The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.

Authors:  Scott Boitano; Justin Hoffman; Andrea N Flynn; Marina N Asiedu; Dipti V Tillu; Zhenyu Zhang; Cara L Sherwood; Candy M Rivas; Kathryn A DeFea; Josef Vagner; Theodore J Price
Journal:  Br J Pharmacol       Date:  2015-08-03       Impact factor: 8.739

7.  Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.

Authors:  Dean P Staus; Ryan T Strachan; Aashish Manglik; Biswaranjan Pani; Alem W Kahsai; Tae Hun Kim; Laura M Wingler; Seungkirl Ahn; Arnab Chatterjee; Ali Masoudi; Andrew C Kruse; Els Pardon; Jan Steyaert; William I Weis; R Scott Prosser; Brian K Kobilka; Tommaso Costa; Robert J Lefkowitz
Journal:  Nature       Date:  2016-07-13       Impact factor: 49.962

8.  Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.

Authors:  D Malfacini; C Ambrosio; M C Gro'; M Sbraccia; C Trapella; R Guerrini; M Bonora; P Pinton; T Costa; G Calo'
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

9.  Thermodynamics of GPCR activation.

Authors:  Xuejun C Zhang; Ye Zhou; Can Cao
Journal:  Biophys Rep       Date:  2016-02-03

10.  Functional competence of a partially engaged GPCR-β-arrestin complex.

Authors:  Punita Kumari; Ashish Srivastava; Ramanuj Banerjee; Eshan Ghosh; Pragya Gupta; Ravi Ranjan; Xin Chen; Bhagyashri Gupta; Charu Gupta; Deepika Jaiman; Arun K Shukla
Journal:  Nat Commun       Date:  2016-11-09       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.